$TXG after strong quarters + raised guidance: what history says about the next day
How TXG has reacted before
| Report | Next-day move |
|---|---|
| Aug 2026 | -0.9% |
| May 2026 | -1.4% |
| Feb 2026 | -1.9% |
| Feb 2026 | +3.5% |
| Nov 2025 | +17.3% |
| May 2025 | +1.6% |
| Feb 2025 | -0.5% |
Median absolute move 1.6% · higher 3 of 7 · n=7
10x Genomics, Inc. Class A Common Stock reports robust Q2 results, raises guidance as production ramps up and costs expected to decline in second half.
How $TXG has reacted to earnings
| Report | Next-day |
|---|---|
| Aug 2026 | -0.9% |
| May 2026 | -1.4% |
| Feb 2026 | -1.9% |
| Feb 2026 | +3.5% |
| Nov 2025 | +17.3% |
| May 2025 | +1.6% |
| Feb 2025 | -0.5% |
Base rate (n=7):
- Median absolute next-day move: 1.6%
- Next-day higher: 3 of 7
- Biggest next-day up: +17.3%
- Biggest next-day down: -1.9%